Not Signed In -
Osteoporosis |
Bone Loss |
Clinical Trial: Study of Investigational Drug in Osteoporosis
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the efficacy and safety of an investigational drug in postmenopausal women with osteoporosis.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Postmenopausal Osteoporosis | | Phase III |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Randomized, Double-Blind, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 50 Years and above, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Postmenopausal women with osteoporosis
Location and Contact Information
Toll Free Number 1-888-577-8839
Pennsylvania
Call for International Site Information, Horsham, Pennsylvania, 19044, United States; Recruiting
More Information
Study ID Numbers: 2004_007
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: September 21, 2004
ClinicalTrials.gov Identifier: NCT00092053
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: September 21, 2004
ClinicalTrials.gov Identifier: NCT00092053
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
